4729-31-02 Prescriptions for sterile products.

When prepared in a fluid therapy pharmacy, drugs shall be dispensed by a pharmacist pursuant to an original patient-specific order issued by a prescriber.

(A) Oral orders, where permitted by law, issued by a prescriber for patients of a fluid therapy pharmacy may be transmitted to a pharmacist by a prescriber or a prescriber's agent. Such orders shall be recorded by the pharmacist noting the full name of the authorized personnel transmitting the order. The original signed prescriptions must remain with the patient's records at the prescriber's office or the institutional facility where it was issued.

(B) Drug orders for patients of a fluid therapy pharmacy transmitted to a pharmacist by the use of a facsimile machine shall only be valid if permitted by law and if a system is in place that will allow the pharmacist to maintain the facsimile as a part of the patient's records including the positive identification of the prescriber and the prescriber's agent as well as identification of the origin of the facsimile. The pharmacist must record the prescription in writing pursuant to section 4729.37 of the Revised Code or store the facsimile copy in such a manner that will allow retention of the drug order for three years from the date of the last transaction. The original signed drug order from which the facsimile is produced shall not be issued to the patient. The original signed drug order must remain with the patient's records at the prescriber's office or the institutional facility where it was issued. A facsimile of a drug order received by a pharmacist in any manner other than transmission directly from the prescriber or the prescriber's agent shall not be considered a valid prescription, except as a copy.

(C) All drug orders for patients of a fluid therapy pharmacy shall include, but are not limited to, at least the following:

(1) Name and address of the patient;

(2) Name, strength, and dosage form of the drug;

(3) Directions for use, including route of administration;

(4) Date prescribed;

(5) Prescriber's positive identification;

(6) Length of therapy or total quantity to be dispensed.

R.C. 119.032 review dates: 09/03/2014 and 06/29/2019
Promulgated Under: 119.03
Statutory Authority: 3719.28 , 4729.26
Rule Amplifies: 3719.06 , 3719.07 , 4729.37
Prior Effective Dates: 3/1/1999, 01/01/2009